Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 8Thoracic 1Genitourinary 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 12Small Cell Lung Carcinoma 4Carcinoma, Renal Cell 4Triple Negative Breast Neoplasms 2Neuroendocrine Tumors 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Mesothelioma 2Thymoma 1Somatostatinoma 1Recurrence 1Pheochromocytoma 1Ovarian Neoplasms 1Multiple Myeloma 1Melanoma 1Insulinoma 1Hereditary Sensory and Autonomic Neuropathies 1Glucagonoma 1Gastrointestinal Neoplasms 1Gastrinoma 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma, Medullary 1Carcinoma, Large Cell 1Carcinoma, Islet Cell 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

pembrolizumab 92Nivolumab 57Cyclophosphamide 22Ipilimumab 17atezolizumab 15Magnetic Resonance Spectroscopy 14Specimen Handling 13Radiosurgery 13Paclitaxel 13Interleukin-2 12Docetaxel 12fludarabine 11Carboplatin 11Pemetrexed 10spartalizumab 9Biopsy 9durvalumab 8Cisplatin 8Radiotherapy 7Immune Checkpoint Inhibitors 7Blood Specimen Collection 7cemiplimab 6avelumab 6aldesleukin 6Taxes 6Gemcitabine 6Drug Therapy 6Bevacizumab 6trametinib 5tislelizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Everolimus × Thoracic × Clear all
NCT00655655 2024-08-21

Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors

Mayo Clinic

Phase 1 Completed
96 enrolled
DermatologicEndocrineGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡